Asanuma Y - Search Results

1

Pharmacogenetics and rheumatology: Molecular mechanisms contributing to variability in drug response.

Asanuma Y, Xie HG, Stein CM. Asanuma Y, et al. Arthritis Rheum. 2005 May;52(5):1349-59. doi: 10.1002/art.21027. Arthritis Rheum. 2005. PMID: 15880820 Free article. Review. No abstract available.

2

Obesity is an independent contributor to functional capacity and inflammation in systemic lupus erythematosus.

Oeser A, Chung CP, Asanuma Y, Avalos I, Stein CM. Oeser A, et al. Among authors: asanuma y. Arthritis Rheum. 2005 Nov;52(11):3651-9. doi: 10.1002/art.21400. Arthritis Rheum. 2005. PMID: 16258902 Free article.

3

Inflammatory mediators and premature coronary atherosclerosis in rheumatoid arthritis.

Rho YH, Chung CP, Oeser A, Solus J, Asanuma Y, Sokka T, Pincus T, Raggi P, Gebretsadik T, Shintani A, Stein CM. Rho YH, et al. Among authors: asanuma y. Arthritis Rheum. 2009 Nov 15;61(11):1580-5. doi: 10.1002/art.25009. Arthritis Rheum. 2009. PMID: 19877084 Free PMC article.

4

Premature coronary-artery atherosclerosis in systemic lupus erythematosus.

Asanuma Y, Oeser A, Shintani AK, Turner E, Olsen N, Fazio S, Linton MF, Raggi P, Stein CM. Asanuma Y, et al. N Engl J Med. 2003 Dec 18;349(25):2407-15. doi: 10.1056/NEJMoa035611. N Engl J Med. 2003. PMID: 14681506 Free article.

5

Increased concentration of proatherogenic inflammatory cytokines in systemic lupus erythematosus: relationship to cardiovascular risk factors.

Asanuma Y, Chung CP, Oeser A, Shintani A, Stanley E, Raggi P, Stein CM. Asanuma Y, et al. J Rheumatol. 2006 Mar;33(3):539-45. Epub 2006 Feb 1. J Rheumatol. 2006. PMID: 16463434

6

Endothelial function in systemic lupus erythematosus: relationship to disease activity, cardiovascular risk factors, corticosteroid therapy, and coronary calcification.

Turner E, Dishy V, Chung CP, Harris P, Pierces R, Asanuma Y, Oeser A, Gebretsadik T, Shintani A, Raggi P, Stein CM. Turner E, et al. Among authors: asanuma y. Vasc Health Risk Manag. 2005;1(4):357-60. doi: 10.2147/vhrm.2005.1.4.357. Vasc Health Risk Manag. 2005. PMID: 17315608 Free PMC article.

7

Effects of C-reactive Protein and Homocysteine on Cytokine Production: Modulation by Pravastatin.

Asanuma Y, Oeser A, Stanley E, Bailey DG, Shintani A, Stein CM. Asanuma Y, et al. Arch Drug Inf. 2008 Jul;1(1):14-22. doi: 10.1111/j.1753-5174.2007.00003.x. Arch Drug Inf. 2008. PMID: 20157364 Free PMC article.

8

Serum osteoprotegerin is increased and independently associated with coronary-artery atherosclerosis in patients with rheumatoid arthritis.

Asanuma Y, Chung CP, Oeser A, Solus JF, Avalos I, Gebretsadik T, Shintani A, Raggi P, Sokka T, Pincus T, Stein CM. Asanuma Y, et al. Atherosclerosis. 2007 Dec;195(2):e135-41. doi: 10.1016/j.atherosclerosis.2007.04.049. Epub 2007 Jun 14. Atherosclerosis. 2007. PMID: 17570371 Free PMC article.

9

Serum lipoprotein(a) and apolipoprotein(a) phenotypes in patients with rheumatoid arthritis.

Asanuma Y, Kawai S, Aoshima H, Kaburaki J, Mizushima Y. Asanuma Y, et al. Arthritis Rheum. 1999 Mar;42(3):443-7. doi: 10.1002/1529-0131(199904)42:3<443::AID-ANR8>3.0.CO;2-Q. Arthritis Rheum. 1999. PMID: 10088766 Free article.

10

Efficacy of tacrolimus in infliximab-refractory progressive rheumatoid arthritis.

Yokota K, Akiyama Y, Asanuma Y, Miyoshi F, Sato K, Mimura T. Yokota K, et al. Among authors: asanuma y. Rheumatol Int. 2009 Feb;29(4):459-61. doi: 10.1007/s00296-008-0694-5. Epub 2008 Sep 18. Rheumatol Int. 2009. PMID: 18802706

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

230 results

Search Page

Filters